Thank you Sign In to enter it. This live web event has ended. Thank you for attending. Contributors Elizabeth Kwong Dr. Elizabeth Kwong retired from Merck after 23 years of service. She currently established her own company (Kwong Eureka Solutions) as a consultant for small start-up companies and specialty drug products. Kwong Eureka Solutions provides pre-clinical support at lead optimization to Phase III studies for formulation selection, bioavailability enhancement, form selection, preparation for GLP and DRF toxicology studies including regulatory filing preparation. Analytical method development to support GMP studies are also its specialties. Before she retired she was Senior Scientific Director at Merck & Co. Basic Pharmaceutical Sciences (BPS) a subdivision of the Department of Pharmaceutical Sciences and Clinical Supplies (PSCS). Elizabeth is the scientific lead for BPS. She is the scientific consultant for the worldwide team for the program support of candidates before nomination. She also leads several initiatives in defining workflow and logistics of lead identification and lead optimization activities in Discovery space. BPS is responsible for supporting the discovery team in the lead ID and Lead Optimization space including selection of formulation to support identification of efficacy model development, selection of candidates for development, identification of safety assessment vehicles for GLP toxicity studies. Robert Wenslow, Ph. D. Robert Wenslow is a seasoned drug development scientist with a strong background in pharmaceutical characterization. He has extensive experience in all solid-state research issues relating to the pharmaceutical industry. At Crystal Pharmatech, he and his team will work with you to speed up your drug discovery, research and development needs at a containable cost. Before joining Crystal Pharmatech, Robert spent 14 years at Merck & Co. His group supported, on average, 30 drug development projects per year. They contributed to salt and polymorph selection, crystallization development and optimization, preparation of registration documents, and specification setting in the area of solid-state support for both bulk drug substance and drug product. Robert received his Ph.D. in Analytical Chemistry from The Pennsylvania State University.